REDWOOD CITY, Calif., March 29, 2021 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today reported financial results ...
Earlier today, Seer released financial results for the fourth quarter and full year ending December 31, 2020. If you have not received this news release, or if you'd like to be added to the company's ...
REDWOOD CITY, Calif., March 01, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report ...
The company also plans a concurrent private placement with investors, including Softbank. A Redwood City company promising to give researchers the tools to gather deep, broad and quick insights into ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. The company has likened its technology's impact on protein ...
Seer, which is developing next-generation proteome analysis tests for biomedical research, announced terms for its IPO on Monday. The Redwood City, CA-based company plans to raise $150 million by ...
Added Salk Institute as collaboration customer and SCIEX as new commercial partnerREDWOOD CITY, Calif., March 29, 2021 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback